Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

11566 from 12310 pages
No results were found for the filter!
PI3K-IN-23
PI3K-IN-23

Item number: TGM-T62409-100mg

Description: PI3K-IN-23 is a (E)-9-oxooctadec-10-en-12-ynoic acid analogue that promotes glucose uptake (EC50: 7.00 µM). Target: Others
MW: 431.59 D
From 1,440.00€ *
Review
Dyrk1A-IN-1
Dyrk1A-IN-1

Item number: TGM-T62414-100mg

Description: Dyrk1A-IN-1 is a triple inhibitor of Dyrk1A kinase activity, tau aggregation, and alpha-syn oligomers, with an IC50 value of 119 nM for Dyrk1A kinase. Target: Others
MW: 432.49 D
From 1,440.00€ *
Review
L-Moses dihydrochloride
L-Moses dihydrochloride

Item number: TGM-T62424-100mg

Description: L-Moses (L-45) dihydrochloride is the first potent and selective inhibitor of the p300/CBP-associated factor (PCAF) bromodomain (Brd) with a dissociation constant (Kd) of 126 nM. Target: Others
MW: 433.38 D
From 4,295.00€ *
Review
KY-02327 acetate
KY-02327 acetate

Item number: TGM-T62436-100mg

Description: KY-02327 acetate is a potent inhibitor of Dishevelled (Dvl)-CXXC5 interactions and is a metabolically stable analog of KY-02061. KY-02327 acetate activates the Wnt/beta-catenin pathway, which in turn promotes osteoblast differentiation. Target: Others
MW: 433.5 D
From 1,450.00€ *
Review
VEGFR-2-IN-14
VEGFR-2-IN-14

Item number: TGM-T62439-100mg

Description: VEGFR-2-IN-14 (Compound 5) is a potent inhibitor of VEGFR-2, effectively inhibiting the growth of HepG2 cells in the Pre-G1 phase and inducing apoptosis. Target: Others
MW: 433.52 D
From 1,440.00€ *
Review
TCMDC-125431
TCMDC-125431

Item number: TGM-T62440-100mg

Description: TCMDC-125431 is a novel inhibitor of Plasmodium calcium kinetics with minimal inhibition of haemoglobin crystals. Target: Others
MW: 433.57 D
From 1,440.00€ *
Review
Tubulin inhibitor 22
Tubulin inhibitor 22

Item number: TGM-T62445-100mg

Description: Tubulin inhibitor 22 (compound 4c) is a potent tubulin inhibitor exhibiting anti-angiogenic and anti-cancer activity, which blocks the cell cycle of MGC-803 cells in the G2/M phase and induces Caspase-mediated apoptosis through mitochondrial dysfunction in a dose-dependent manner. Target: Others
MW: 434.26 D
From 1,440.00€ *
Review
HIV-1 inhibitor-40
HIV-1 inhibitor-40

Item number: TGM-T62452-100mg

Description: HIV-1 inhibitor-40 (Compound 4ab), an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) with an EC50 of 1.9 nM, exhibits no significant acute toxicity in vivo and functions as a highly sensitive inhibitor of the orexin receptor antagonist CYP. Target: Others
MW: 434.45 D
From 1,440.00€ *
Review
beta-Secretase Inhibitor III
beta-Secretase Inhibitor III

Item number: TGM-T62455-100mg

Description: beta-Secretase Inhibitor III is a highly selective inhibitor of BACE1 with a Ki value of 0.13 nM. Target: Others
MW: 434.46 D
From 1,440.00€ *
Review
Urease-IN-1
Urease-IN-1

Item number: TGM-T62465-100mg

Description: Urease -IN-1 is a urease inhibitor (IC50: 2.21±0.45 µM). Target: Others
MW: 435.27 D
From 1,440.00€ *
Review
HBV-IN-18
HBV-IN-18

Item number: TGM-T62467-100mg

Description: HBV-IN-18 (Compound 3) is an HBV capsid assembly modulator (CpAM) with an EC50 of 2790 nM. Target: Others
MW: 435.32 D
From 1,440.00€ *
Review
CB1/2 agonist 1
CB1/2 agonist 1

Item number: TGM-T62468-100mg

Description: CB1/2 agonist 1 is a potent CB1/2 agonist that crosses the blood-brain barrier, acting on CB1R (EC50: 56.15 nM) and CB2R (EC50: 11.63 nM). It reduces glutamate release and LPS-induced microglia activation, exhibiting anti-inflammatory and analgesic activities, with potential for multiple sclerosis...
MW: 435.33 D
Please request pricing for this article.
Review
11566 from 12310 pages